Biohit Oyj
HEL: BIOBV.HE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Helsinki
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Osmo Antero Suovaniemi
- Employees
- 46
- Headquarters
- Helsinki, Finland
- IPO year
- 2000
- Market cap
- €36.1M
- Website
- https://www.biohithealthcare.com
Loading BIOBV…
Loading profile data…Frequently asked questions about BIOBV
What does Biohit Oyj (BIOBV.HE) do?
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company's diagnostic tests product range includes the GastroPanel test for diagnosing diseases of the stomach and associated risks; Biohit Active B12, a test for measuring the levels of act...
Where does BIOBV.HE trade?
Biohit Oyj (BIOBV.HE) trades on the NASDAQ Helsinki.
What sector is BIOBV.HE in?
Biohit Oyj (BIOBV.HE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biohit Oyj?
Osmo Antero Suovaniemi is the chief executive officer of Biohit Oyj (BIOBV.HE).
Where is Biohit Oyj headquartered?
Biohit Oyj is headquartered in Finland.
Does BIOBV.HE pay a dividend?
Biohit Oyj (BIOBV.HE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOBV.HE go public?
Biohit Oyj (BIOBV.HE) completed its initial public offering in 2000.